Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 525

1.

Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, Chen CJ.

J Clin Oncol. 2010 May 10;28(14):2437-44. doi: 10.1200/JCO.2009.27.4456. Epub 2010 Apr 5.

PMID:
20368541
2.

Natural history of chronic hepatitis B REVEALed.

Chen CJ, Yang HI.

J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. Review.

PMID:
21323729
3.

Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.

Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, Su J, Sun CA, Liaw YF, Chen CJ; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL-HBV) Study Group.

Gastroenterology. 2010 May;138(5):1747-54. doi: 10.1053/j.gastro.2010.01.042. Epub 2010 Jan 28.

PMID:
20114048
4.

Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.

Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, You SL, Wang LY, Chen CJ; R.E.V.E.A.L.-HBV Study Group.

Hepatology. 2013 Aug;58(2):546-54. doi: 10.1002/hep.26385.

PMID:
23504622
5.

Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.

Chen CF, Lee WC, Yang HI, Chang HC, Jen CL, Iloeje UH, Su J, Hsiao CK, Wang LY, You SL, Lu SN, Chen CJ; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL–HBV) Study Group.

Gastroenterology. 2011 Oct;141(4):1240-8, 1248.e1-2. doi: 10.1053/j.gastro.2011.06.036. Epub 2011 Jun 22.

PMID:
21703214
6.

Long-term follow-up of patients with hepatitis B e antigen negative chronic hepatitis B.

Bekku D, Arai M, Imazeki F, Yonemitsu Y, Kanda T, Fujiwara K, Fukai K, Sato K, Itoga S, Nomura F, Yokosuka O.

J Gastroenterol Hepatol. 2011 Jan;26(1):122-8. doi: 10.1111/j.1440-1746.2010.06322.x.

PMID:
21175805
7.

Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.

Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS.

J Gastroenterol Hepatol. 2011 Nov;26(11):1638-45. doi: 10.1111/j.1440-1746.2011.06777.x.

PMID:
22011297
8.

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ.

J Natl Cancer Inst. 2005 Feb 16;97(4):265-72.

PMID:
15713961
9.

High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.

Chan HL, Tse CH, Mo F, Koh J, Wong VW, Wong GL, Lam Chan S, Yeo W, Sung JJ, Mok TS.

J Clin Oncol. 2008 Jan 10;26(2):177-82. doi: 10.1200/JCO.2007.13.2043.

PMID:
18182659
10.

Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.

Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan X, Chen J, Cheng S, Schaefer S, Cao G.

Carcinogenesis. 2008 Sep;29(9):1685-91. doi: 10.1093/carcin/bgm301. Epub 2008 Jan 12.

PMID:
18192693
11.

Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.

Chen CH, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.

Liver Int. 2007 Aug;27(6):806-15.

PMID:
17617124
12.

Risk stratification for hepatitis B virus related hepatocellular carcinoma.

Lin CL, Kao JH.

J Gastroenterol Hepatol. 2013 Jan;28(1):10-7. doi: 10.1111/jgh.12010.

PMID:
23094699
13.

Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.

Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.

J Natl Cancer Inst. 2009 Jul 15;101(14):1019-27. doi: 10.1093/jnci/djp146. Epub 2009 Jun 17.

PMID:
19535774
14.

Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.

Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Wang LY, You SL, Iloeje UH, Chen CJ; REVEAL-HBV Study Group.

Gastroenterology. 2010 Aug;139(2):474-82. doi: 10.1053/j.gastro.2010.04.048. Epub 2010 Apr 29.

PMID:
20434450
15.

Natural history of chronic hepatitis B: what exactly has REVEAL revealed?

Iloeje UH, Yang HI, Chen CJ.

Liver Int. 2012 Oct;32(9):1333-41. doi: 10.1111/j.1478-3231.2012.02805.x. Epub 2012 Apr 17. Review.

PMID:
22510145
16.

Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B.

Jeng WJ, Sheen IS, Liaw YF.

Clin Gastroenterol Hepatol. 2010 Jun;8(6):541-5. doi: 10.1016/j.cgh.2010.02.023. Epub 2010 Mar 16.

PMID:
20298811
17.

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.

Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G.

J Natl Cancer Inst. 2009 Aug 5;101(15):1066-82. doi: 10.1093/jnci/djp180. Epub 2009 Jul 2.

18.

Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.

Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M.

J Gastroenterol Hepatol. 2008 Mar;23(3):474-81. doi: 10.1111/j.1440-1746.2008.05321.x.

PMID:
18318825
19.

Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.

Lin CL, Kao JH.

J Biomed Sci. 2008 Mar;15(2):137-45. Epub 2007 Dec 5. Review.

PMID:
18058038
20.

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

Yuen MF, Yuan HJ, Wong DK, Yuen JC, Wong WM, Chan AO, Wong BC, Lai KC, Lai CL.

Gut. 2005 Nov;54(11):1610-4. Epub 2005 May 4.

Supplemental Content

Support Center